FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

39296411000001109: Sofosbuvir 200mg / Velpatasvir 50mg tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Jan 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1727991000001115 Sofosbuvir 200mg / Velpatasvir 50mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1728001000001110 Sofosbuvir 200mg / Velpatasvir 50mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sofosbuvir 200mg / Velpatasvir 50mg tablets Is a Sofosbuvir + Velpatasvir true Inferred relationship Existential restriction modifier
Sofosbuvir 200mg / Velpatasvir 50mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Sofosbuvir 200mg / Velpatasvir 50mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Sofosbuvir 200mg / Velpatasvir 50mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Sofosbuvir 200mg / Velpatasvir 50mg tablets Has specific active ingredient Sofosbuvir true Inferred relationship Existential restriction modifier
Sofosbuvir 200mg / Velpatasvir 50mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Sofosbuvir 200mg / Velpatasvir 50mg tablets Is a Sofosbuvir + Velpatasvir false Inferred relationship Existential restriction modifier
Sofosbuvir 200mg / Velpatasvir 50mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sofosbuvir 200mg / Velpatasvir 50mg tablets Has specific active ingredient Velpatasvir true Inferred relationship Existential restriction modifier
Sofosbuvir 200mg / Velpatasvir 50mg tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sofosbuvir 200mg / Velpatasvir 50mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Sofosbuvir 200mg / Velpatasvir 50mg tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Sofosbuvir 200mg / Velpatasvir 50mg tablets Has active ingredient Sofosbuvir false Inferred relationship Existential restriction modifier
Sofosbuvir 200mg / Velpatasvir 50mg tablets Plays role Antiviral therapeutic role true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Sofosbuvir 200mg / Velpatasvir 50mg tablets 28 tablet Has VMP True Sofosbuvir 200mg / Velpatasvir 50mg tablets Inferred relationship Existential restriction modifier
Epclusa 200mg/50mg tablets (Gilead Sciences Ltd) Is a True Sofosbuvir 200mg / Velpatasvir 50mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start